A detailed history of Schonfeld Strategic Advisors LLC transactions in A Ikido Pharma Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 17,700 shares of AIKI stock, worth $67,260. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,700
Holding current value
$67,260
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
N/A
17,700 New
17,700 $67,000

Others Institutions Holding AIKI

About AIkido Pharma Inc.


  • Ticker AIKI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,485,100
  • Market Cap $20.8M
  • Description
  • AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small mo...
More about AIKI
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.